Oncology Clinical Research

Clinical Development
Oncology Clinical Trials

Flexible solutions to accelerate your oncology breakthrough

Every year, cancer takes the lives of millions. While the world waits for potential cures and access to treatment, biotech companies are in a race to get new therapeutics to market quickly.

However, with complex oncology trials and the many unknowns that come with next generation therapies, there are endless hurdles. Your scientific discoveries deserve an innovative approach to clinical development.

As a full-service oncology CRO, we are dedicated to supporting biotech and emerging biopharma companies through every phase of development. Our extensive oncology expertise coupled with an end-to-end approach helps accelerate your clinical programs, giving you confidence to bring breakthrough treatments to patients, faster.

Having a streamlined clinical development process can mean the difference between success and failure for emerging biotechs. We’re dedicated to providing end-to-end, consultative solutions and services -- from lab development to clinical delivery.

Erin Finot , Vice President, Immuno-Oncology & CAGT

Leading oncology expertise

Oncology is IQVIA Biotech’s largest area of focus.

Our strong foundation of therapeutic, scientific, and operational expertise enables us to bring unparalleled innovation to oncology clinical development, making your trial more precise, predictable and efficient.

500+ studies/70,000 patients in the past 5 years
Experience working in 66 countries
16 FDA approved oncology therapies
Board-certified oncologists and hematologists on staff
Global oncology key opinion leaders and site networks
Global oncology regulatory expertise

EARLY PHASE ONCOLOGY

Our extensive early phase oncology experience enables us to guide your program through the intricacies inherent in dose-finding and dose-optimization, safety and proof-of-concept studies in a sick patient population. We look beyond first-in-human, and are active in a range of adaptive, basket and umbrella designs, as well as complex multi-arm platform design trials.

Global network of specialist Phase I oncology sites
Technology solutions for enhanced cohort planning and management
Modeling and simulation of multiple datasets to identify optimal dose of novel targeted and immune therapies
Laboratory services from Q² Solutions for biomarker services, assay validation and development of companion diagnostics

LATE PHASE ONCOLOGY

We offer modern solutions for patient-focused trials that accelerate enrollment, reduce site burden, and deliver trials on time and budget.

Proven decentralized trial solutions
Global network of trial sites to optimize patient recruitment
Precision site selection, centralized monitoring, and automated safety case processing
Global regulatory expertise

Experience by phase

Early and late phase expertise

IQVIA Biotech has staff with specific early phase and late phase experience to address the nuances of different phases of development and can grow with you as your pipeline matures.

Trending Topics in Oncology

Blog

From Innovation to Collaboration: How Project Optimus is Influencing Emerging Biopharma and Biotech

Publication

Diving deeper into understanding patient care implications of growing oncology R&D advances: notable takeaways from ESMO and ASH 2023

Oncology Clinical Trials

Flexible solutions to accelerate your oncology breakthrough

Leading oncology expertise

Early and late phase expertise

Trending Topics in Oncology

Cell and Gene Therapy

Connected Intelligence for oncology clinical development

IQVIA Biotech's oncology resource center

Email Us